Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Dynamic susceptibility contrast 19F-MRI of inhaled perfluoropropane: a novel approach to combined pulmonary ventilation and perfusion imaging

Lookup NU author(s): Dr Mary NealORCiD, Dr Ben PippardORCiD, Professor John SimpsonORCiD, Professor Peter ThelwallORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2019 The Authors. Magnetic Resonance in Medicine published by Wiley Periodicals, Inc. on behalf of International Society for Magnetic Resonance in MedicinePurpose: To assess alveolar perfusion by applying dynamic susceptibility contrast MRI to 19F-MRI of inhaled perfluoropropane (PFP). We hypothesized that passage of gadolinium-based contrast agent (GBCA) through the pulmonary microvasculature would reduce magnetic susceptibility differences between water and gas components of the lung, elevating the T* 2 of PFP. Methods: Lung-representative phantoms were constructed of aqueous PFP-filled foams to characterize the impact of aqueous/gas phase magnetic susceptibility differences on PFP T* 2. Aqueous phase magnetic susceptibility was modulated by addition of different concentrations of GBCA. In vivo studies were performed to measure the impact of intravenously administered GBCA on the T* 2 of inhaled PFP in mice (7.0 Tesla) and in healthy volunteers (3.0 Tesla). Results: Perfluoropropane T* 2 was sensitive to modulation of magnetic susceptibility difference between gas and water components of the lung, both in phantom models and in vivo. Negation of aqueous/gas phase magnetic susceptibility difference was achieved in lung-representative phantoms and in mice, resulting in a ~2 to 3× elevation in PFP T* 2 (3.7 to 8.5 ms and 0.7 to 2.6 ms, respectively). Human studies demonstrated a transient elevation of inhaled PFP T* 2 (1.50 to 1.64 ms) during passage of GBCA bolus through the lung circulation, demonstrating sensitivity to lung perfusion. Conclusion: We demonstrate indirect detection of a GBCA in the pulmonary microvasculature via changes to the T* 2 of gas phase PFP within directly adjacent alveoli. This approach holds potential for assessing alveolar perfusion by dynamic susceptibility contrast 19F-MRI of inhaled PFP, with concurrent assessment of lung ventilation properties, relevant to lung physiology and disease.


Publication metadata

Author(s): Neal MA, Pippard BJ, Simpson AJ, Thelwall PE

Publication type: Article

Publication status: Published

Journal: Magnetic Resonance in Medicine

Year: 2020

Volume: 83

Issue: 2

Pages: 452-461

Print publication date: 01/02/2020

Online publication date: 29/08/2019

Acceptance date: 16/07/2019

Date deposited: 02/09/2019

ISSN (print): 0740-3194

ISSN (electronic): 1522-2594

Publisher: John Wiley and Sons Inc.

URL: https://doi.org/10.1002/mrm.27933

DOI: 10.1002/mrm.27933


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
MC/PC/16054
MR/N018915/1Medical Research Council (MRC)

Share